{"id":338,"date":"2021-06-17T08:29:00","date_gmt":"2021-06-17T08:29:00","guid":{"rendered":"http:\/\/nouveausiteintegragen2.local\/?p=338"},"modified":"2024-09-06T06:24:59","modified_gmt":"2024-09-06T06:24:59","slug":"nouveau-look-nouveau-portefeuille-nouvelles-opportunites","status":"publish","type":"post","link":"https:\/\/integragen.com\/en\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/","title":{"rendered":"NEW LOOK. NEW PORTFOLIO. NEW OPPORTUNITIES."},"content":{"rendered":"<h4 class=\"wp-block-heading\"><strong>FOLLOWING ITS ACQUISITION BY ONCODNA, INTEGRAGEN HAS UNDERGONE A COMPLETE OVERHAUL AND IS NOW READY TO EMBARK ON NEW PROJECTS IN THE FIELDS OF CANCER AND GENETIC DISEASES.<\/strong><\/h4>\n\n\n\n<p>Since the successful tender offer in November 2020, IntegraGen has been working hand in hand with&nbsp;<strong><a href=\"https:\/\/www.oncodna.com\/en\/main\/home\/\" target=\"_blank\" rel=\"noreferrer noopener\">OncoDNA<\/a><\/strong>&nbsp;the consolidation of their teams and services. The acquisition has brought together two companies with complementary expertise. While IntegraGen is a leading player in DNA sequencing services, OncoDNA is a world-renowned company specializing in precision medicine for cancer treatment. The Belgian company offers&nbsp;<a href=\"https:\/\/www.oncodna.com\/en\/healthcare-providers\/our-diagnostic-solutions\/oncodeep\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>comprehensive biomarker tests<\/strong><\/a>&nbsp;to support clinical decision-making and guide towards the most appropriate treatments. OncoDNA also offers&nbsp;<a href=\"https:\/\/www.oncodna.com\/en\/healthcare-providers\/our-diagnostic-solutions\/monitoring-solution\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>liquid biopsy<\/strong><\/a>&nbsp;enabling real-time monitoring of patients' response to treatment and the progression of their disease. Since its inception in 2012, OncoDNA has disrupted technological innovation in the field of molecular profiling and has been recognized for its continued exponential growth.<\/p>\n\n\n\n<p>Within the OncoDNA group, IntegraGen will leverage the power of next-generation sequencing to facilitate the<strong>access to therapeutic innovation in the hospital environment<\/strong>&nbsp;and exert a greater influence on the quality of patient care. This integration has given rise to a European leader in precision medicine, now able to offer a wide range of products and services.&nbsp;<strong>unique, highly integrated portfolio covering the needs of every link in the value chain<\/strong>These range from translational research and drug development to patient treatment and follow-up.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>IN FIGURES :<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>An experienced team of\u00a0<strong>more than 100 employees<\/strong>Our team of geneticists, clinicians and biostatisticians is here to support your projects.<\/li>\n\n\n\n<li>Molecular profiling charts and clinical recommendations for\u00a0<strong>60,000 cancer patients<\/strong><\/li>\n\n\n\n<li>Our proprietary database of over\u00a0<strong>4,500,000 genetic variants<\/strong>,\u00a0<strong>1,150 cancer drugs<\/strong>,\u00a0<strong>data from 7,000 clinical trials<\/strong><\/li>\n\n\n\n<li><strong>2 partner laboratories<\/strong>\u00a0in Europe and the United States<\/li>\n\n\n\n<li>An international presence in over\u00a0<strong>50 countries<\/strong><\/li>\n\n\n\n<li>A pioneer in comprehensive biomarker testing (<strong>2014<\/strong>) and liquid biopsy (<strong>2016<\/strong>)<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p>June 16, 2021<\/p>\n\n\n\n<p>Share :<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/integragen.com\/en\/fr\/actualites\/bladder-cancer-development-2\/\">Potential involvement of urinary tract infections in the development of bladder cancer<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/integragen.com\/en\/fr\/actualites\/antoine-lacassagne-projet-cancer-colorectal\/\">IntegraGen supports the Centre Antoine Lacassagne in Nice for a large-scale research project on colorectal cancer patients<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>FOLLOWING ITS ACQUISITION BY ONCODNA, INTEGRAGEN HAS UNDERGONE A COMPLETE OVERHAUL AND IS NOW READY TO TAKE ON NEW PROJECTS IN THE FIELDS OF CANCER AND GENETIC DISEASES. Since the successful takeover bid in November 2020, IntegraGen has been working hand-in-hand with OncoDNA to consolidate their teams and services. The acquisition...<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ca_portfolio_gallery_project_year":"","ca_portfolio_gallery_client":"","ca_portfolio_gallery_skills":"","ca_portfolio_gallery_url":"","ca_portfolio_gallery_images":"","_eb_attr":"","footnotes":""},"categories":[5,1],"tags":[],"class_list":["post-338","post","type-post","status-publish","format-standard","hentry","category-actualite","category-toutes-les-categories"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NOUVEAU LOOK. NOUVEAU PORTEFEUILLE. NOUVELLES OPPORTUNIT\u00c9S.<\/title>\n<meta name=\"description\" content=\"\u00c0 LA SUITE DE SON ACQUISITION PAR ONCODNA, INTEGRAGEN FAIT PEAU NEUVE ET EST FIN PR\u00caTE \u00c0 ENTREPRENDRE DE NOUVEAUX PROJETS DANS LES DOMAINES DU CANCER ET\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/integragen.com\/en\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NOUVEAU LOOK. NOUVEAU PORTEFEUILLE. NOUVELLES OPPORTUNIT\u00c9S.\" \/>\n<meta property=\"og:description\" content=\"\u00c0 LA SUITE DE SON ACQUISITION PAR ONCODNA, INTEGRAGEN FAIT PEAU NEUVE ET EST FIN PR\u00caTE \u00c0 ENTREPRENDRE DE NOUVEAUX PROJETS DANS LES DOMAINES DU CANCER ET\" \/>\n<meta property=\"og:url\" content=\"https:\/\/integragen.com\/en\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/\" \/>\n<meta property=\"og:site_name\" content=\"IntegraGen\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-17T08:29:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-06T06:24:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/integragen.com\/wp-content\/uploads\/2024\/07\/image-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2478\" \/>\n\t<meta property=\"og:image:height\" content=\"684\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"borel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"borel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\\\/\"},\"author\":{\"name\":\"borel\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/person\\\/f6280b21a3de1be99b206a61b1b27cd8\"},\"headline\":\"NOUVEAU LOOK. NOUVEAU PORTEFEUILLE. NOUVELLES OPPORTUNIT\u00c9S.\",\"datePublished\":\"2021-06-17T08:29:00+00:00\",\"dateModified\":\"2024-09-06T06:24:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\\\/\"},\"wordCount\":454,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Toutes les Cat\u00e9gories\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\\\/\",\"url\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\\\/\",\"name\":\"NOUVEAU LOOK. NOUVEAU PORTEFEUILLE. NOUVELLES OPPORTUNIT\u00c9S.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#website\"},\"datePublished\":\"2021-06-17T08:29:00+00:00\",\"dateModified\":\"2024-09-06T06:24:59+00:00\",\"description\":\"\u00c0 LA SUITE DE SON ACQUISITION PAR ONCODNA, INTEGRAGEN FAIT PEAU NEUVE ET EST FIN PR\u00caTE \u00c0 ENTREPRENDRE DE NOUVEAUX PROJETS DANS LES DOMAINES DU CANCER ET\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/integragen.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\\\/\\\/integragen.com\\\/actualite\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"NOUVEAU LOOK. NOUVEAU PORTEFEUILLE. NOUVELLES OPPORTUNIT\u00c9S.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#website\",\"url\":\"https:\\\/\\\/integragen.com\\\/\",\"name\":\"IntegraGen - Clinical Genomic Experts\",\"description\":\"NGS Sequencing &amp; Bioinformatics for Pharma, Biotech &amp; CRO\",\"publisher\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\"},\"alternateName\":\"IntegraGen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/integragen.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\",\"name\":\"IntegraGen\",\"url\":\"https:\\\/\\\/integragen.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Logo_IntegraGen_OncoDNA.png\",\"contentUrl\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Logo_IntegraGen_OncoDNA.png\",\"width\":2478,\"height\":684,\"caption\":\"IntegraGen\"},\"image\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/integragen\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/person\\\/f6280b21a3de1be99b206a61b1b27cd8\",\"name\":\"borel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g\",\"caption\":\"borel\"},\"sameAs\":[\"http:\\\/\\\/nouveausiteintegragen2.local\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NEW LOOK. NEW PORTFOLIO. NEW OPPORTUNITIES.","description":"FOLLOWING ITS ACQUISITION BY ONCODNA, INTEGRAGEN HAS UNDERGONE A COMPLETE OVERHAUL AND IS NOW READY TO EMBARK ON NEW PROJECTS IN THE FIELDS OF CANCER AND CANCER TREATMENT.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/integragen.com\/en\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/","og_locale":"en_US","og_type":"article","og_title":"NOUVEAU LOOK. NOUVEAU PORTEFEUILLE. NOUVELLES OPPORTUNIT\u00c9S.","og_description":"\u00c0 LA SUITE DE SON ACQUISITION PAR ONCODNA, INTEGRAGEN FAIT PEAU NEUVE ET EST FIN PR\u00caTE \u00c0 ENTREPRENDRE DE NOUVEAUX PROJETS DANS LES DOMAINES DU CANCER ET","og_url":"https:\/\/integragen.com\/en\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/","og_site_name":"IntegraGen","article_published_time":"2021-06-17T08:29:00+00:00","article_modified_time":"2024-09-06T06:24:59+00:00","og_image":[{"width":2478,"height":684,"url":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/07\/image-1.png","type":"image\/png"}],"author":"borel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"borel","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/integragen.com\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/#article","isPartOf":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/"},"author":{"name":"borel","@id":"https:\/\/integragen.com\/#\/schema\/person\/f6280b21a3de1be99b206a61b1b27cd8"},"headline":"NOUVEAU LOOK. NOUVEAU PORTEFEUILLE. NOUVELLES OPPORTUNIT\u00c9S.","datePublished":"2021-06-17T08:29:00+00:00","dateModified":"2024-09-06T06:24:59+00:00","mainEntityOfPage":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/"},"wordCount":454,"commentCount":0,"publisher":{"@id":"https:\/\/integragen.com\/#organization"},"articleSection":["Actualit\u00e9s","Toutes les Cat\u00e9gories"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/integragen.com\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/integragen.com\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/","url":"https:\/\/integragen.com\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/","name":"NEW LOOK. NEW PORTFOLIO. NEW OPPORTUNITIES.","isPartOf":{"@id":"https:\/\/integragen.com\/#website"},"datePublished":"2021-06-17T08:29:00+00:00","dateModified":"2024-09-06T06:24:59+00:00","description":"FOLLOWING ITS ACQUISITION BY ONCODNA, INTEGRAGEN HAS UNDERGONE A COMPLETE OVERHAUL AND IS NOW READY TO EMBARK ON NEW PROJECTS IN THE FIELDS OF CANCER AND CANCER TREATMENT.","breadcrumb":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/integragen.com\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/integragen.com\/toutes-les-categories\/nouveau-look-nouveau-portefeuille-nouvelles-opportunites\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/integragen.com\/"},{"@type":"ListItem","position":2,"name":"Actualit\u00e9s","item":"https:\/\/integragen.com\/actualite\/"},{"@type":"ListItem","position":3,"name":"NOUVEAU LOOK. NOUVEAU PORTEFEUILLE. NOUVELLES OPPORTUNIT\u00c9S."}]},{"@type":"WebSite","@id":"https:\/\/integragen.com\/#website","url":"https:\/\/integragen.com\/","name":"IntegraGen - Clinical Genomic Experts","description":"NGS Sequencing &amp; Bioinformatics for Pharma, Biotech &amp; CROs","publisher":{"@id":"https:\/\/integragen.com\/#organization"},"alternateName":"IntegraGen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/integragen.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/integragen.com\/#organization","name":"IntegraGen","url":"https:\/\/integragen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/integragen.com\/#\/schema\/logo\/image\/","url":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/09\/Logo_IntegraGen_OncoDNA.png","contentUrl":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/09\/Logo_IntegraGen_OncoDNA.png","width":2478,"height":684,"caption":"IntegraGen"},"image":{"@id":"https:\/\/integragen.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/integragen\/"]},{"@type":"Person","@id":"https:\/\/integragen.com\/#\/schema\/person\/f6280b21a3de1be99b206a61b1b27cd8","name":"borel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g","caption":"borel"},"sameAs":["http:\/\/nouveausiteintegragen2.local"]}]}},"_links":{"self":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/comments?post=338"}],"version-history":[{"count":1,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/338\/revisions"}],"predecessor-version":[{"id":2729,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/338\/revisions\/2729"}],"wp:attachment":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/media?parent=338"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/categories?post=338"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/tags?post=338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}